JCB logo
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published 20 November 2006. doi:10.1083/jcb.200602149
The Rockefeller University Press, 0021-9525 $8.00
JCB, Volume 175, Number 4, 607-617
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 4831K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Song, L.
Right arrow Articles by Huang, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Song, L.
Right arrow Articles by Huang, C.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Article

IKKß programs to turn on the GADD45{alpha}–MKK4–JNK apoptotic cascade specifically via p50 NF-{kappa}B in arsenite response



Lun Song1, Jingxia Li1, Dongyun Zhang1, Zheng-gang Liu2, Jianping Ye3, Qimin Zhan4, Han-Ming Shen5, Matt Whiteman6, and Chuanshu Huang1

1 Nelson Institute of Environmental Medicine, New York University School of Medicine, Tuxedo, NY 10987
2 Cell and Cancer Biology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
3 Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, LA 70808
4 National Key Laboratory of Molecular Oncology, Cancer Institute, Chinese Academy of Medical Science, Peking Union Medical College, Beijing, 100021, People's Republic of China
5 Department of Community, Occupational, and Family Medicine and 6 Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore 117597, Singapore

Correspondence to Chuanshu Huang: chuanshu{at}env.med.nyu.edu

Cross talk between NF-{kappa}B and c-Jun N-terminal kinases (JNKs) has been implicated in the cell life and death decision under various stresses. Functional suppression of JNK activation by NF-{kappa}B has recently been proposed as a key cellular survival mechanism and contributes to cancer cells escaping from apoptosis. We provide a novel scenario of the proapoptotic role of I{kappa}B kinase ß (IKKß)–NF-{kappa}B, which can act as the activator of the JNK pathway through the induction of GADD45{alpha} for triggering MKK4/JNK activation, in response to the stimulation of arsenite, a cancer therapeutic reagent. This effect of IKKß–NF-{kappa}B is dependent on p50 but not the p65/relA NF-{kappa}B subunit, which can increase the stability of GADD45{alpha} protein through suppressing its ubiquitination and proteasome-dependent degradation. IKKß–NF-{kappa}B can therefore either activate or suppress the JNK cascade and consequently mediate pro- or antiapoptotic effects, depending on the manner of its induction. Furthermore, the NF-{kappa}B p50 subunit can exert a novel regulatory function on protein modification independent of the classical NF-{kappa}B transcriptional activity.

Abbreviations used in this paper: CHX, cyclohexamide; GADD, growth arrest and DNA damage inducible; IKK, I{kappa}B kinase; MEF, mouse embryonic fibroblast; PARP, poly (ADP-ribose) polymerase; WT, wild-type.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents